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STRAIN AND SEX DIFFERENCES IN KIDNEY 
CARCINOGENESIS IN RATS TREATED WITH 
N-ETHYL-N-HYDROXYETHYLNITROSAMINE 
AND URACIL 
Yukitaka Yamada, Munehisa Takashi, Takao Sakata, Yojiro Nakano, 
Yasuharu Takagi, Hatsuki Hibi and Koji Miyake 
From the Department of Urology, Nagoya University School of Medicine 
We earlier demonstrated that simultaneous administration of EHEN and uracil for 3 weeks 
resulted in enhancement of renal carcinogenesis in F344 female rats. Therefore, to establish a 
model of renal carcinogenesis in rats that can induce advanced renal carcinoma at a high 
incidence, differences in the susceptibility to N-ethyl-N-hydroxyethylnitrosamine (EHEN) and 
uracil of the kidneys ;n male and female rats of two strains were examined. Group I (male 
Wi star rats), group 2 (female Wistar rats), group 3 (male F344 rats) and group 4 (female F344 
rats) received a 3-week simultaneous administration of 0.05% EHEN in the drinking water and 
3% uracil in the diet after one week's acclimation. In all the above four groups, the rats were 
thereafter given a basal diet and water without chemical addition for a 29-week period. Group 5 
(male Wistar rats), group 6 (female Wistar rats), group 7 (male F344 rats) and group 8 (female 
F344 rats) received no chemicals for the entire 33 weeks. At the end of the experiment, renal 
adenocarcinomas were found in 85, 68, 14 and 0% of the rats in groups I, 2, 3 and 4, respectively. 
The incidence of adenomas and adenocarcinomas in Wistar rats were significantly greater than in 
F344 rats (p<O.OOOI). These findings indicate strain and poss!biy sex differences in kidney carci-
nogenesis in rats treated with EHEN and uracil, and simultaneous administration of the two agents 
to male Wistar rats might have an advantage for models to induce advanced renal carcinoma at 
a high incidence. 
(Acta Urol. Jpn. 41: 781-787, 1995) 
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INTRODUCTION 
Several chemicals are known to induce 
renal epithelial tumors in rats, including 
N-ethyl-N-hydroxyethylnitrosamine (EHE-
N) 1), dimethylnitrosamine2), N-nitrosomor-
pholine3), N-(4-fluoro-4-biphenylyl) aceta-
mide~), and streptozotocin5). EHEN in 
particular induces renal epithelial cancers 
selectively in rats6) and several substances 
have been found to enhance EHEN-initia-
ted lesion development. 
Lalich first reported that uracil, a com-
ponent of ribodeoxynucleic acid, induces 
urolithiasis in rats when given by p.o. ad-
ministration7). Shirai et at. demonstrated 
that mucosal papillomatosis of the urinary 
bladder is associated with this urolithiasis 
and that severe epithelial hyperplasia is 
caused in F344 rats receiving 3% uracil in 
the diet8) Furthermore, Shirai et at. re-
ported that 3% uracil given by p.o. admin-
istration strongly promotes urinary blad-
der carcinogenesis after N-butyl-N-(4-hy-
droxybutyl) nitrosamine (BBN) initiation, 
suggesting that prolonged stimulation by 
uracil-induced urolithiasis results in chro-
nic cell proliferation of the bladder epi-
thelium9). We earlier demonstrated that 
simultaneous administration of EHEN and 
uracil for 3 weeks resulted in enhancement 
of renal carcinogenesis in F344 female 
rats26). We conducted the present investi-
gation to compare kidney lesion induction 
in male and female Wistar and F344 rats 
treated with EHEN and uracil. 
MATERIALS AND METHODS 
I. Animals and chemicals 
A total of 240 animals, equal numbers 
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of male and female F344 and Wistar rats, 
4 weeks old, were obtained from Charles 
River japan, Inc. (Kanagawa, japan). The 
animals were kept in a room at 25±2°C, 
with a relative humidity of 55±5% and 
a l2-h light 12-b1 dark cycle, and were given 
basal diet (Oriental M, Oriental Yeast 
Co., Tokyo, japan) and water. EHEN 
(Sakai Research Laboratories, Fukui, ja-
pan) was dissolved in the drinking water 
at a concentration of 0.05% and admini-
stered in light-opaque bottles. Uracil (Ya-
mas a Shoyu Co. Ltd., Chiba, japan) was 
mixed in a powdered basal diet at a con-
centration of 3%. 
2. Experimental schedule 
The animals were kept on the basal diet 
for a oneweek acclimation before the 
beginning of the experiment. They were 
divided into eight groups of 30 rats each. 
Group I consisted of male Wistar rats, 
Group 2 female Wistar rats, Group 3 male 
F344 rats. Group 4 female F344 rats, 
Group 5 male Wistar rats, Group 6 female 
Wistar rats, Group 7 male F344 rats, and 
Group 8 female F344 rats. The rats in 
groups 1,2,3 and 4 were simultaneously 
given 0.05% EHEN and 3% uracil for 3 
weeks. The rats in groups 1~4 were given 
the basal diet and water without chemical 
addition for a 29 week period after these 
treatments. The rats in groups 5~8 re-
ceived no chemicals in the diet and water 
for the entire 33 weeks. 
Body weights and consumption of diet 
and water were recorded weekly for the first 
4 weeks. At the end of week 33, all surviv-
ing animals were killed for examination 
under ether anesthesia, and all major or-
gans examined for macroscopic change. 
Body, kidney, and liver weights and organ 
per body. weight ratios were determined 
for each group. The kidneys, liver, and 
other organs were removed and fixed in 1& 
% phosphate-buffered formalin. The uri-
nary bladder was inflated in situ with 10% 
phosphate-buffered formalin, then removed 
and fixed in the same fixative. These 
organs were processed routinely and sec-
tions stained with hematoxylin and eosin 
for histological examination. 
Kidney lesions were classified into mi-
croadenomas, adenomas, and adenocar-
cinomas, as described previouslylO,II). 
Lesions less than 0.5 mm in diameter, ap-
proximately three times the diameter of a 
glomerulus, were tentatively classified as 
microadenomas and those more than 0.5 
mm in diameter as adenomas, the latter 
showing clear compression of surrounding 
tissue. The lesions diagnosed as carcino-
mas were composed of irregularly arranged 
cells with occasional mitotic figures. 
3. Statistical analysis 
Data were expressed as mean values ± 
SD and analyzed using the Student's t-test. 
Differences in incidence of lesions were 
evaluated using the chi-square test or 
Fisher's exact probability test when indi-
cated. 
RESULTS 
I. General observations 
During the experimental period a total 
of 21 rats died. The final number of ani-
mals in each group are shown as the effec-
tive numbers of rats in Table I. Fig. I 
illustrates the changes of body weights in 
Table 1. Mean final body, kidney and liver weights 
Group Strain and sex Treatment Effective Final body Right and left kidney weight, g Liver weight, g 
no. of rats weight, g (% of body weight) (% of body weight) 
Wistar, male EHEN + uracil 20 546±63.9" 8.02±1O.5" (1.5 ±1.9 ) 25.3 ±5.65" (4.64±0.92) 
Wistar, female EHEN + uracil 22 313±43.2' 4.21± 4.48"(1.45±1.6 ) 15.07±4.47" (4. 79± 1.24) 
F344, male EHEN + uracil 28 343±26.7" 2.53± 0.21" (0. 74±0.06) 19.57±8.85" (5.84±3.46) 
4 F344, female EHEN + uracil 30 195±13.7 1.49± 0.17 (0.76±0.06) 8.57 ± 1.76" (4.38±0. 73) 
5 Wistar, male None 30 671 ±84.3 3.83± 0.44 (0.5S±0.06) 21.3 ±3.S9 (3.16±0.3i) 
6 Wistar, female None 30 335±29.3 2.27± 0.17 (O.6S±0.04) 9.62± 1.01 (2.SS±0.23) 
7 F344, male None 30 37S±21.8 2.46± O.IS (O.65±0.03) 11.65±0.98 (3.0S±0.15) 
S F344, female None 29 194± 10.5 1.42± 0.09 (0.74±0.03) 5.99±0.4B (3.09±0.IS) 
All values are mean±SD. Significantly different from the respective control group at p<0.05' or 0.01", 
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Fig. 1. Changes of body weights in rats of experimental and control groups 
Fig. 2. (A) Gross appearance of a tumor of the left kidney in a rat 
treated with 0.05% EHEN and 3% uracil (group 1) (B) A 
microadenoma of the kidney (HE staining, x 75) (C) An 
adenoma of the kidney (HE staining, x70) (D) An adeno-
carcinoma of the kidney (HE staining, x 70) 
rats treated with 0.05% EHEN and 3% 
uracil for 3 weeks (groups I ~4), At the 
start of the experiment no differences in 
body weights of rats were found among 
groups. Administration of EHEN and 
uracil for 3 weeks suppressed the growth of 
the rats, After returning to normal water 
and basal diet, rats gained body weight 
normally. Table I shows the final body 
weights for each group. Rats in groups 
I ~3 still had significantly lower body 
weights than the respective control rats in 
groups 5~7 . 
Total doses of EHEN ingested Over 3 
weeks, calculated from water consumption 
data, were 2,25 mg/g (body weight) in 
group I, 1.63 mg/g in group 2, 1.75 mg/g in 
group 3, and 1.58 mg/g in group 4. Total 
amounts of uracil given over 3 weeks, 
obtained from food consumption data , 
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Table 2. Incidences of neoplastic lesions in the kidneys of treated rats 
Neoplastic lesions 
Total no. of Effective Group Strain and sex neoplastic lesions Microadenoma Adenoma Adenocarcinoma 
no. of rats No. (%) No. (%) No.(%) No. (%) 
I Wistar, male 20 20 (100) I ( 5) 2 (10) 17 (85) 
2 Wistar, female 22 21 ( 95) o ( 0) 6 (27) 15 (68) 
F344, male 28 20 ( 71) 7 (25) 9 (32) 4 (14) 
4 F344, female 30 18 ( 60) II (37) 7 (23) o ( 0) 
Each rat is tabulated in the column of the most advanced lesion present in the kidneys as determined by 
histopathological examination. No neoplastic lesions were found in control rats in groups 5-8. 
were 51.5 mgjg (body weight) in group 1, 
55.0 mgjg in group 2, 34.9 mgjg in group 3, 
and 37.2 mgjg in group 4. 
2. Kidney 
Table 1 shows the kidney weights and 
kidney to body weight ratios. Kidney to 
body weight ratios in groups 1, 2, and 3 
were significantly higher than those in the 
respective control groups. Renal tumors 
were observed in groups 1, 2, 3 and 4. 
Most were grayish-white, round, and lo-
cated in the renal cortex. Fig. 2A shows 
the gross and microscopic appearance of a 
typical renal tumor. 
Histologically, renal tumors were com-
posed of tubular, cord-like or papillary 
structures made up of cells with basophilic 
or sometimes clear cytoplasm. Table 2 
shows the incidence of renal lesions classi-
fied into microadenomas, adenomas, and 
adenocarcinomas (Fig. 2B~2D). Each 
rat is tabulated in the column of the most 
advanced lesion present ·in its kidney. 
The incidence of adenocarcinomas in Wis-
tar rats (group 1 or 2) were significantly 
higher than that in F344 rats (group 3 or 
4), (p<O.OOOI). No significant difference 
was found in the incidence of neoplastic 
lesions between the male and female rats 
in the same strain. No kidney mesenchy-
mal tumors were observed. 
3. Liver 
Liver weights and liver to body weight 
ratios are also shown on the right side of 
Table I, values in groups 1,2,3 and 4 being 
significantly higher than those of control 
rats in groups 5, 6, 7 and 8 respectively. 
Histologically, the livers of rats treated 
with EHEN and uracil had multiple le-
sions including hepatocellular carcinomas. 
DISCUSSION 
Druckrey et ai.I) first reported that EH-
EN induces tumors in the kidneys, liver, 
and ovaries of rats. Hiasa et ai.G) showed 
that renal tubular cell tumors selectively 
develop at a high incidence, without other 
kinds of renal tumors, in Wistar rats treat-
ed with 0.1% EHEN in the diet for 2 
weeks. Hirose et ai.12) revealed that 0.01% 
EHEN in drinking water for 2 weeks in-
duces tumors in kidneys and liver of F344 
rats. The present study demonstrated that 
simultaneous administration of 0.05% EH-
EN in drinking water and 3% uracil in 
diet for 3 weeks causes renal carcinomas 
in rats at a high frequency. 
Several substances have been shown to 
exert promotive effects on renal carcinogen-
esis in rats treated with EHEN. Ohshi-
rna et ai.I3) showed that injection of (3-
cyclodextrin, which is known to induce 
injury of renal tubules, for one week resulted 
in an increased incidence of renal cell 
tumors in rats treated with 0.01% EHEN 
for 2 weeks. Kurata et ai.14) also reported 
that para-aminophenol stimulated the mi-
totic activity of preneoplastic tubular lesions 
in the kidney. Thus, many nephrotoxic 
substances including N-(3,5-dichlorophenyl) 
succinimid!5), citrinin!G), basic lead 
acetate!7). trisodium nitrilotriacetate!~) 
have been reported as promoters of renal 
carcinogenesis. Presumably nephrotoxic 
effects causing tubular injury and conse-
quent stimulation of reactive tubular 
proliferation are involved. 
Uracil by p.o. administration causes uro-
lithiasis in rats?). Uracil has no mutagenic 
properties19) and no marked influence 
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on the urinary pB or Na ion concen-
tration20) Several studies which have 
showed that uracil-induced calculi strongly 
promote BBN induced urinary bladder 
carcinogenesis add support to the 
hypothesis that enhancement of cell prolif-
eration within the urothelium, associated 
with irritant effects, is an important event 
for promotion of bladder chemical 
carcinogenesis in rats. Since uracil has 
no mutagenic properties, its carcinogenic 
activity is thought to rely on chronic 
mechanical stimulation. The schedule 
applied in the present study featured 
simultaneous administration of EBEN 
and uracil but it is unlikely that uracil 
would chemically interact with EBEN or 
alter its metabolism in rats in vivo. Its 
influence is concluded to be primarily 
due to an increase in the susceptibility 
of the target cells to carcinogen. We 
recently have shown that simultaneous 
administration of BBN and uracil induces 
transitional cell carcinomas and squamous 
cell carcinomas in the renal pelvis of rats 
at high rates21 ). 
Differences in the susceptibility of cer-
tain organs in various animal strains and 
species to carcinogens have been widely 
examined. In urinary bladder carcinoge-
nesis, Fukushima et al. reported a higher 
tumor incidence in male ACI rats than in 
male Wistar, F 344 and Sprague- Dawley 
rats treated with sodium saccharin25). Bio-
chemical studies on susceptibility factors 
have focused on genetic differences In 
carcinogen metabolism. Thus differences 
in the metabolic pathways for activation 
of carcinogens may account for the di-
fferences in response among strains. 
The present study indicates that there 
are differences in the susceptibility to 
EB EN and uracil of the kidney in two 
strains of rats, with Wistar animals being 
extremely sensitive. Despite a tendency 
for lower values in females, no significant 
variation in the incidence of renal tumors 
in different sexes was evident. We previ-
ously demonstrated that the incidence of 
renal adenocarcinomas at the end of week 
52 was 53% in female F344 rats treated 
with EBEN and uracil for 3 weeks26). In 
the present case, the observed incidence 
was 0%. One of the causes of these differ-
ent results might be the short duration 
of the experimental period. Previous stud-
ies documented incidences of renal adeno-
carcinomas in rats treated with EBEN 
as an initiator to be 0~13% at best14 ,22-24l. 
In the present study, the incidence of renal 
adenocarcinoma in male Wistar rats treated 
with EBEN and uracil for only 3 weeks 
was 85% after only a relatively short-term 
observation. Thus, simultaneous admini-
stration of the two agents to male Wistar 
rats might have an advantage for models 
requiring induction of advanced renal 
carcinoma at a high incidence. 
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N-ethy1-1V-hydroxyethvlnitrosamine(EHEN)
とウ ラ シル の 同 時投 与 に よ る ラ ッ ト腎腫 瘍 の発 生 率 に
つ いて 性 差,系 統差 を検 討 した.1.実 験 動 物1第1
群,第5群(Wistarラ ッ ト,雄i),第2群,第6群
(Wistarラ"ト,雌),第3群,第7群(F344ラ ッ ト.
雄),第4群,第8群(F344ラ ッ ト,雌)の8群 で,
各 群30匹,合 計240匹の ラ ッ トを用 い た.2.実 験 方
法'第1群 か ら第4群 ま でが 薬 剤投 与 群,第5群 か ら
第8群 ま でが 薬 剤非 投 与 の対 照 群 と した 。 薬 剤 投 与 群
に は 飲 料水 中 に0.05%EHENを,粉 末 飼 料 中 に3
%ウ ラ シル を 混 入 して,こ れ を3週 間 同 時 に 投 与 し
*現:愛知県厚生連江南昭和病院泌尿器科
た.全 実 験 期 間 は33週間 と した.3.結 果=実 験 終 了
時 の有 効 動 物 匹 数 は,第1群 か ら第8群 ま で それ ぞれ,
20,22,28,30,30,30,30,29匹で あ った.腎 腫 瘍
の発 生 率 は,第1,2,3,4群 で それ ぞ れ100%,
95%,71%,60%であ り,Wistarラッ トでF344ラ
ッ トよ りも有 意 に 高 率 に 腎腫 瘍 の発 生 が み られ た 。 性
差 に よ る発 生 率 の差 に つ い て は,雄 に 高 率 に発 生 す る
傾 向 が あ った が,有 意 差 は なか った.対 照 群 には 腎 腫
瘍 は 発 生 し な か った.Wistar雄iラッ トに,EHEN
とウ ラ シル を 同時 に投 与す れ ば,短 期 間 に高 頻度 に 腎
腫 瘍 を 誘 発 させ うる こ とが示 され た.
(泌尿紀 要41:781-787,1995)
